157 related articles for article (PubMed ID: 38235361)
41. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
Briner AE; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
[TBL] [Abstract][Full Text] [Related]
42. AcrIIA5 Inhibits a Broad Range of Cas9 Orthologs by Preventing DNA Target Cleavage.
Song G; Zhang F; Zhang X; Gao X; Zhu X; Fan D; Tian Y
Cell Rep; 2019 Nov; 29(9):2579-2589.e4. PubMed ID: 31775029
[TBL] [Abstract][Full Text] [Related]
43. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
[TBL] [Abstract][Full Text] [Related]
44. Distinct Subcellular Localization of a Type I CRISPR Complex and the Cas3 Nuclease in Bacteria.
Govindarajan S; Borges A; Karambelkar S; Bondy-Denomy J
J Bacteriol; 2022 May; 204(5):e0010522. PubMed ID: 35389256
[TBL] [Abstract][Full Text] [Related]
45. A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9.
Dagdas YS; Chen JS; Sternberg SH; Doudna JA; Yildiz A
Sci Adv; 2017 Aug; 3(8):eaao0027. PubMed ID: 28808686
[TBL] [Abstract][Full Text] [Related]
46. Increasing the Activity of the High-Fidelity SpyCas9 Form in Yeast by Directed Mutagenesis of the PAM-Interacting Domain.
Davletshin AI; Matveeva AA; Bachurin SS; Karpov DS; Garbuz DG
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203615
[TBL] [Abstract][Full Text] [Related]
47. Probing the Dynamics of
Zhdanova PV; Chernonosov AA; Prokhorova DV; Stepanov GA; Kanazhevskaya LY; Koval VV
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163047
[TBL] [Abstract][Full Text] [Related]
48. Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer.
Mahendra C; Christie KA; Osuna BA; Pinilla-Redondo R; Kleinstiver BP; Bondy-Denomy J
Nat Microbiol; 2020 Apr; 5(4):620-629. PubMed ID: 32218510
[TBL] [Abstract][Full Text] [Related]
49. Enhanced Bacterial Immunity and Mammalian Genome Editing via RNA-Polymerase-Mediated Dislodging of Cas9 from Double-Strand DNA Breaks.
Clarke R; Heler R; MacDougall MS; Yeo NC; Chavez A; Regan M; Hanakahi L; Church GM; Marraffini LA; Merrill BJ
Mol Cell; 2018 Jul; 71(1):42-55.e8. PubMed ID: 29979968
[TBL] [Abstract][Full Text] [Related]
50. Valproic Acid Thermally Destabilizes and Inhibits SpyCas9 Activity.
Cheng X
Mol Ther; 2020 Dec; 28(12):2635-2641. PubMed ID: 32882179
[TBL] [Abstract][Full Text] [Related]
51. Structure and Dynamics of the CRISPR-Cas9 Catalytic Complex.
Palermo G
J Chem Inf Model; 2019 May; 59(5):2394-2406. PubMed ID: 30763088
[TBL] [Abstract][Full Text] [Related]
52. Dynamics changes of CRISPR-Cas9 systems induced by high fidelity mutations.
Zheng L; Shi J; Mu Y
Phys Chem Chem Phys; 2018 Nov; 20(43):27439-27448. PubMed ID: 30357163
[TBL] [Abstract][Full Text] [Related]
53. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
[TBL] [Abstract][Full Text] [Related]
54. Key role of the REC lobe during CRISPR-Cas9 activation by 'sensing', 'regulating', and 'locking' the catalytic HNH domain.
Palermo G; Chen JS; Ricci CG; Rivalta I; Jinek M; Batista VS; Doudna JA; McCammon JA
Q Rev Biophys; 2018; 51():. PubMed ID: 30555184
[TBL] [Abstract][Full Text] [Related]
55. CRISPR-Cas9 Structures and Mechanisms.
Jiang F; Doudna JA
Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
[TBL] [Abstract][Full Text] [Related]
56. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
57. Inhibition mechanisms of CRISPR-Cas9 by AcrIIA17 and AcrIIA18.
Wang X; Li X; Ma Y; He J; Liu X; Yu G; Yin H; Zhang H
Nucleic Acids Res; 2022 Jan; 50(1):512-521. PubMed ID: 34893860
[TBL] [Abstract][Full Text] [Related]
58. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.
Ma E; Harrington LB; O'Connell MR; Zhou K; Doudna JA
Mol Cell; 2015 Nov; 60(3):398-407. PubMed ID: 26545076
[TBL] [Abstract][Full Text] [Related]
59. Characterization of a Type II-A CRISPR-Cas System in
Mosterd C; Moineau S
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581075
[No Abstract] [Full Text] [Related]
60. Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.
Mekler V; Kuznedelov K; Severinov K
J Biol Chem; 2020 May; 295(19):6509-6517. PubMed ID: 32241913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
